Welcome to LookChem.com Sign In|Join Free

CAS

  • or

875573-67-4

Post Buying Request

875573-67-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

875573-67-4 Usage

Uses

(7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol is used in the synthetic preparation of 7α-alkylated 19-norsteroids.

Check Digit Verification of cas no

The CAS Registry Mumber 875573-67-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,5,5,7 and 3 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 875573-67:
(8*8)+(7*7)+(6*5)+(5*5)+(4*7)+(3*3)+(2*6)+(1*7)=224
224 % 10 = 4
So 875573-67-4 is a valid CAS Registry Number.

875573-67-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name (7R,8R,9S,13S,14S,17S)-7-(9-bromononyl)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol

1.2 Other means of identification

Product number -
Other names (7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:875573-67-4 SDS

875573-67-4Synthetic route

(+)-(7α)-[9-bromononyl]estra-1,3,5(10)-triene-3-ol-17β-yl acetate
875573-66-3

(+)-(7α)-[9-bromononyl]estra-1,3,5(10)-triene-3-ol-17β-yl acetate

7α-(9-bromononyl)estra-1,3,5(10)-triene-3,17β-diol
875573-67-4

7α-(9-bromononyl)estra-1,3,5(10)-triene-3,17β-diol

Conditions
ConditionsYield
With methanol; water; hydrogen bromide at 60℃; for 0.8h;
With hydrogen bromide In methanol at 60℃; for 2h; Temperature;4.3 g
With hydrogen bromide In methanol for 3h; Reflux; Large scale;4.8 kg
9-bromononan-1-ol
55362-80-6

9-bromononan-1-ol

7α-(9-bromononyl)estra-1,3,5(10)-triene-3,17β-diol
875573-67-4

7α-(9-bromononyl)estra-1,3,5(10)-triene-3,17β-diol

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: 1H-imidazole; formaldehyd / toluene / 5 h / 0 - 5 °C / Large scale
2.1: magnesium / tetrahydrofuran / 4.33 h / 50 - 65 °C / Inert atmosphere; Large scale
2.2: 1 h / -30 - -15 °C / Inert atmosphere; Large scale
3.1: triphenylphosphine; bromine / dichloromethane / 3 h / -10 - 25 °C / Inert atmosphere; Large scale
4.1: copper(ll) bromide; lithium bromide / acetonitrile / 3 h / 20 °C / Large scale
5.1: hydrogen bromide / methanol / 3 h / Reflux; Large scale
View Scheme
ω-bromononanyl dimethyl-tert-butylsilyl ether
149051-24-1

ω-bromononanyl dimethyl-tert-butylsilyl ether

7α-(9-bromononyl)estra-1,3,5(10)-triene-3,17β-diol
875573-67-4

7α-(9-bromononyl)estra-1,3,5(10)-triene-3,17β-diol

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: magnesium / tetrahydrofuran / 4.33 h / 50 - 65 °C / Inert atmosphere; Large scale
1.2: 1 h / -30 - -15 °C / Inert atmosphere; Large scale
2.1: triphenylphosphine; bromine / dichloromethane / 3 h / -10 - 25 °C / Inert atmosphere; Large scale
3.1: copper(ll) bromide; lithium bromide / acetonitrile / 3 h / 20 °C / Large scale
4.1: hydrogen bromide / methanol / 3 h / Reflux; Large scale
View Scheme
7α-[9-(tert-butyldimethylsiloxy)nonyl]estr-4-ene-17β-acetate-3-one
875573-60-7

7α-[9-(tert-butyldimethylsiloxy)nonyl]estr-4-ene-17β-acetate-3-one

7α-(9-bromononyl)estra-1,3,5(10)-triene-3,17β-diol
875573-67-4

7α-(9-bromononyl)estra-1,3,5(10)-triene-3,17β-diol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: triphenylphosphine; bromine / dichloromethane / 3 h / -10 - 25 °C / Inert atmosphere; Large scale
2: copper(ll) bromide; lithium bromide / acetonitrile / 3 h / 20 °C / Large scale
3: hydrogen bromide / methanol / 3 h / Reflux; Large scale
View Scheme
(+)-3-oxo-(7α)-[9-bromononyl]estr-4-en-17β-ylacetate
875573-63-0

(+)-3-oxo-(7α)-[9-bromononyl]estr-4-en-17β-ylacetate

7α-(9-bromononyl)estra-1,3,5(10)-triene-3,17β-diol
875573-67-4

7α-(9-bromononyl)estra-1,3,5(10)-triene-3,17β-diol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: copper(ll) bromide; lithium bromide / acetonitrile / 3 h / 20 °C / Large scale
2: hydrogen bromide / methanol / 3 h / Reflux; Large scale
View Scheme
7α-(9-bromononyl)estra-1,3,5(10)-triene-3,17β-diol
875573-67-4

7α-(9-bromononyl)estra-1,3,5(10)-triene-3,17β-diol

S-(4,4,5,5,5-pentafluoropentyl)isothiourea p-nitrobenzenesulfonate

S-(4,4,5,5,5-pentafluoropentyl)isothiourea p-nitrobenzenesulfonate

(+)-(7α)-[9-(4,4,5,5,5-pentafluoropentylsulfanyl)nonyl]estra-1,3,5(10)-triene-3,17β-diol
153004-31-0

(+)-(7α)-[9-(4,4,5,5,5-pentafluoropentylsulfanyl)nonyl]estra-1,3,5(10)-triene-3,17β-diol

Conditions
ConditionsYield
With sodium hydroxide In water; N,N-dimethyl-formamide at 0 - 15℃; for 1.5h; Large scale;100%
7α-(9-bromononyl)estra-1,3,5(10)-triene-3,17β-diol
875573-67-4

7α-(9-bromononyl)estra-1,3,5(10)-triene-3,17β-diol

4,4,5,5,5-pentafluoro-1-pentanethiol
148757-88-4

4,4,5,5,5-pentafluoro-1-pentanethiol

(+)-(7α)-[9-(4,4,5,5,5-pentafluoropentylsulfanyl)nonyl]estra-1,3,5(10)-triene-3,17β-diol
153004-31-0

(+)-(7α)-[9-(4,4,5,5,5-pentafluoropentylsulfanyl)nonyl]estra-1,3,5(10)-triene-3,17β-diol

Conditions
ConditionsYield
With sodium hydroxide In N,N-dimethyl acetamide; water for 1h; Product distribution / selectivity;
7α-(9-bromononyl)estra-1,3,5(10)-triene-3,17β-diol
875573-67-4

7α-(9-bromononyl)estra-1,3,5(10)-triene-3,17β-diol

thiourea
17356-08-0

thiourea

BrH*C28H44N2O2S

BrH*C28H44N2O2S

Conditions
ConditionsYield
In N,N-dimethyl acetamide at 80℃; for 16h;

875573-67-4Relevant articles and documents

Impurity control method of fulvestrant

-

, (2020/09/23)

The invention belongs to the field of pharmaceutical chemicals, and relates to a fulvestrant impurity control method, which is characterized in that from the introduction of chiral carbon to the synthesis of a fulvestrant intermediate compound represented by a formula VII-1, multi-step and step-by-step control is performed on 7beta isomer impurities, so that the 7beta isomer content of the VII-1 compound is between 0.1% and 0.3%, and finally the qualified fulvestrant bulk drug with stable quality is prepared. The impurity control method is simple to operate, low in production cost and high intotal yield, and can be applied to large-scale industrial production.

Process for the preparation of 7alpha-alkylated 19-norsteroids

-

Page/Page column 25, (2008/06/13)

Processes useful in the preparation of pharmaceutical compounds such as fulvestrant and processes for the preparation of fulvestrant.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 875573-67-4